IN BRIEF: Faron Pharmaceuticals Chair Tuomo Patsi adds to shareholding
Faron Pharmaceuticals Ltd - Turku, Finland-based developer of cancer immunotherapies - Non-Executive Chair Tuomo Patsi buys 21,500 ordinary shares at €2.435 per share on Monday...
Wed, 02/07/2025 - 13:23